Gu, Tao <br/><br/>
Osteopontin is involved in the development of acquired chemo-resistance of cisplatin in small cell lung cancer.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  Nov 2009 
 - 176-83 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-8332 
<br/><br/><label>Standard No.: </label>10.1016/j.lungcan.2009.02.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Caspase 3--metabolism<br/>Caspase 9--metabolism<br/>Cell Line, Tumor<br/>Cisplatin--therapeutic use<br/>Down-Regulation<br/>Drug Resistance, Neoplasm--genetics<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Osteopontin--metabolism<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>RNA, Messenger--metabolism<br/>Small Cell Lung Carcinoma--drug therapy<br/>Transfection